×

Use of AVE0010 for the treatment of diabetes mellitus type 2

  • US 9,981,013 B2
  • Filed: 08/15/2016
  • Issued: 05/29/2018
  • Est. Priority Date: 08/30/2010
  • Status: Active Grant
First Claim
Patent Images

1. A method of improving glycemic control in a patient with type 2 diabetes mellitus comprising:

  • administering a dose of 10 μ

    g lixisenatide to the patient once daily for 14 days, andadministering a dose of 20 μ

    g lixisenatide to the patient once daily starting on day 15 of lixisenatide treatment.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×